157 results on '"Cobo Ibáñez, Tatiana"'
Search Results
2. Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry.
3. Myo-Spain: Spanish Registry of patients with idiopathic inflammatory myopathy. Methodology
4. Myo-Spain: Registro de pacientes con miopatía inflamatoria idiopática de España. Metodología
5. Development of an application for mobile phones (App) based on the collaboration between the Spanish Society of Rheumatology and Spanish Society of Family Medicine for the referral of systemic autoimmune diseases from primary care to rheumatology
6. Desarrollo de una aplicación para teléfonos móviles (app) basada en la colaboración Sociedad Española de Reumatología/Sociedad Española de Medicina de Familia y Comunitaria para derivación de enfermedades autoinmunes sistémicas
7. Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs—Findings From the BIOCOVID Study
8. Clinical Characteristics of Juvenile Idiopathic Inflammatory Myopathy and Comparison With Adult Patients: Analysis From a Multicentric Cohort in Spain
9. Multicenter Registry on Inflammatory Myositis From the Rheumatology Society in Madrid, Spain: Descriptive Analysis
10. Registro de pacientes con miopatía inflamatoria de la Sociedad Madrileña de Reumatología: análisis descriptivo
11. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project
12. The effect of smoking on clinical and structural damage in patients with axial spondyloarthritis: A systematic literature review
13. Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review
14. Terapia biológica secuencial con rituximab-belimumab en pacientes con nefritis lúpica recurrente
15. „ Hiker's feet ” bei einem Patienten mit Anti‐PM‐Scl‐Autoantikörpern und idiopathischer entzündlicher Myopathie
16. “Hiker's feet” in a patient with anti‐PM‐Scl autoantibodies‐associated idiopathic inflammatory myopathy
17. Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain
18. Cutaneous manifestations in idiopathic inflammatory myopathies
19. Efficacy and safety of rituximab in the treatment of non-renal systemic lupus erythematosus: A systematic review
20. Multidisciplinary dermatology–rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review
21. Preventing organ damage in systemic lupus erythematosus: the impact of early biological treatment
22. Raynaud's phenomenon and digital ischaemia induced by ixekizumab.
23. One year clinical and ultrasonographic follow up of the Pilot Study for the Referral of Patients with Early Spondyloarthritis (ESPIDEP)
24. Seguimiento clínico y ecográfico a 1 año del EStudio PIloto de Derivación de pacientes con Espondiloartritis Precoz (ESPIDEP)
25. Biological sequential therapy with rituximab-belimumab in patients with recurrent lupus nephritis
26. Serious infections in patients with rheumatoid arthritis and other immune-mediated connective tissue diseases exposed to anti-TNF or rituximab: data from the Spanish registry BIOBADASER 2.0
27. Myo-Spain: Spanish Registry of patients with idiopathic inflammatory myopathy. Methodology
28. Profilaxis antiinfecciosa necesaria en pacientes adultos con enfermedades reumáticas
29. Automated radiofrequency-based US measurement of common carotid intima–media thickness in RA patients treated with synthetic vs synthetic and biologic DMARDs
30. Biological sequential therapy with rituximab-belimumab in patients with recurrent lupus nephritis
31. Incidence of COVID-19 in 902 Patients With Immunomediated Inflammatory Diseases Treated With Biologics and Targeted Synthetic Disease-Modifying Antirheumatic Drugs—Findings From the BIOCOVID Study
32. Clinical Characteristics of Juvenile Idiopathic Inflammatory Myopathy and Comparison With Adult Patients
33. Diagnostic accuracy of enthesis ultrasound in the diagnosis of early spondyloarthritis
34. Enthesis inflammation in recurrent acute anterior uveitis without spondylarthritis
35. Peripheral Blood T Lymphocytes From Patients With Early Rheumatoid Arthritis Express RANKL and Interleukin-15 on the Cell Surface and Promote Osteoclastogenesis in Autologous Monocytes
36. Hormonal Dependence and Cancer in Systemic Lupus Erythematosus
37. AB0206 IS DISEASE SEVERITY A RISK FACTOR FOR CARDIOVASCULAR MORTALITY IN INFLAMMATORY MYOSITIS? ANALYSIS OF THE REGISTRY OF INFLAMMATORY MYOSITIS FROM THE MADRID COMMUNITY (REMICAM)
38. AB0205 TREATMENT OF INFLAMMATORY MYOSITIS IN CLINICAL PRACTICE: ANALYSIS OF THE REGISTRY OF INFLAMMATORY MYOSITIS FROM THE MADRID COMMUNITY (REMICAM)
39. THU0334 EFFECT OF THE DELAY FROM INITIAL SYMPTOMS TO DIAGNOSIS OR THERAPY INITIATION, ON DISEASE CONTROL AND MORTALITY, IN INFLAMMATORY MIOSITIS PATIENTS FROM THE INFLAMMATORY MIOSITIS REGISTRY FROM THE MADRID COMMUNITY (REMICAM)
40. Overlap myositis, a distinct entity beyond primary inflammatory myositis: A retrospective analysis of a large cohort from the REMICAM registry
41. 121 Comparison of clinical and laboratory profiles in 3575 systemic lupus erythematosus patients with and without Sjögrens syndrome: data from the spanish society for rheumatology lupus registry
42. Cardiovascular mortality and cardiovascular event rates in patients with inflammatory rheumatic diseases in the CARdiovascular in rheuMAtology (CARMA) prospective study—results at 5 years of follow-up.
43. Efficacy and safety of biological therapy compared to synthetic immunomodulatory drugs or placebo in the treatment of Behçet’s disease associated uveitis: a systematic review
44. Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease
45. Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project
46. Fiebre chikungunya importada en Madrid
47. Imported Chikungunya Fever in Madrid
48. Long-term pulmonary outcomes and mortality in idiopathic inflammatory myopathies associated with interstitial lung disease.
49. Multidisciplinary dermatology–rheumatology management for patients with moderate-to-severe psoriasis and psoriatic arthritis: a systematic review
50. Efficacy and Safety of Nonbiologic Immunosuppressants in the Treatment of Nonrenal Systemic Lupus Erythematosus: A Systematic Review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.